Prostate cancers in men under the age of 50: about a series in Togo, Sub-Saharan Africa.
Adenocarcinoma
Cancer
Prostate
Togo
Young adult
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
21 Dec 2022
21 Dec 2022
Historique:
received:
08
09
2022
accepted:
07
12
2022
entrez:
21
12
2022
pubmed:
22
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Prostate cancer is a public health problem and increasingly diagnosed in men under 50 years of age. This cancer occurs much more in subjects of advanced age, generally over sixty. The aim of the study was to describe the epidemiological, clinical and histopathological aspects of prostate cancer in men under the age of 50 in Togo. It was a retrospective descriptive, cross-sectional study of histologically confirmed cases of prostate cancer in young adults at the Pathological Laboratory of Lomé over a period of 10 years (2011-2020). In total, 29 cases of prostate cancer in patients under 50 years of age. The proportion of prostate cancers in men under 50 was 0.7% of all prostate cancers, The average age of the patients was 45 years with extremes of 35 and 49 years. Twelve patients had a family history of prostate cancer, with a statistically significant relationship between the existence of a family history of prostate cancer and the age of onset of the cancer (p-value = 0.03). The dominant clinical information was prostatic hypertrophy (40.37%), followed by acute urine retention (20.69%) and micturition disorders (17.27%). The median Prostate Specific Antigen (PSA) was 188 ng/ml with extremes of 20 ng/ml and 2100 ng/ml. A large proportion of patients had a PSA between 100 and 500 ng/ml. Histologically, they were all prostatic acinar adenocarcinomas. These adenocarcinomas were well differentiated (48%) and moderately differentiated (38%). The predominant histoprognostic grade was ISUP (International Society of Urological Pathology) grade 1 which was noted in 65.52%, followed by grade 2 in 20.69%. Prostate cancer in men under 50 years of age is relatively rare in Togo, sometimes occurring in the context of a family history of prostate cancer. Hence the importance of raising awareness among the male population, especially with a family history of prostate cancer, to start screening early, around the age of 40.
Sections du résumé
BACKGROUND
BACKGROUND
Prostate cancer is a public health problem and increasingly diagnosed in men under 50 years of age. This cancer occurs much more in subjects of advanced age, generally over sixty. The aim of the study was to describe the epidemiological, clinical and histopathological aspects of prostate cancer in men under the age of 50 in Togo.
METHODS
METHODS
It was a retrospective descriptive, cross-sectional study of histologically confirmed cases of prostate cancer in young adults at the Pathological Laboratory of Lomé over a period of 10 years (2011-2020).
RESULTS
RESULTS
In total, 29 cases of prostate cancer in patients under 50 years of age. The proportion of prostate cancers in men under 50 was 0.7% of all prostate cancers, The average age of the patients was 45 years with extremes of 35 and 49 years. Twelve patients had a family history of prostate cancer, with a statistically significant relationship between the existence of a family history of prostate cancer and the age of onset of the cancer (p-value = 0.03). The dominant clinical information was prostatic hypertrophy (40.37%), followed by acute urine retention (20.69%) and micturition disorders (17.27%). The median Prostate Specific Antigen (PSA) was 188 ng/ml with extremes of 20 ng/ml and 2100 ng/ml. A large proportion of patients had a PSA between 100 and 500 ng/ml. Histologically, they were all prostatic acinar adenocarcinomas. These adenocarcinomas were well differentiated (48%) and moderately differentiated (38%). The predominant histoprognostic grade was ISUP (International Society of Urological Pathology) grade 1 which was noted in 65.52%, followed by grade 2 in 20.69%.
CONCLUSION
CONCLUSIONS
Prostate cancer in men under 50 years of age is relatively rare in Togo, sometimes occurring in the context of a family history of prostate cancer. Hence the importance of raising awareness among the male population, especially with a family history of prostate cancer, to start screening early, around the age of 40.
Identifiants
pubmed: 36544122
doi: 10.1186/s12885-022-10425-6
pii: 10.1186/s12885-022-10425-6
pmc: PMC9773477
doi:
Substances chimiques
Prostate-Specific Antigen
EC 3.4.21.77
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1341Informations de copyright
© 2022. The Author(s).
Références
Cancer. 1994 Sep 15;74(6):1768-77
pubmed: 8082080
SAGE Open Med. 2021 Jul 17;9:20503121211032812
pubmed: 34349998
J Clin Pathol. 2015 Jul;68(7):511-5
pubmed: 25837493
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Urol. 2002 Nov;168(5):1980-3; discussion 1983-4
pubmed: 12394689
Asian Pac J Cancer Prev. ;18(2):491-494
pubmed: 28345835
Adv Exp Med Biol. 2018;1095:1-14
pubmed: 30229546
Prog Urol. 2011 Apr;21(4):260-3
pubmed: 21482400
Urology. 2004 Feb;63(2):337-41
pubmed: 14972485
Urology. 2006 May;67(5):1028-32
pubmed: 16698363
Hinyokika Kiyo. 2008 Feb;54(2):139-42
pubmed: 18323175
J Chin Med Assoc. 2017 Jan;80(1):39-43
pubmed: 27914715
Acta Med Indones. 2016 Jul;48(3):228-238
pubmed: 27840359
CA Cancer J Clin. 2013 Jan;63(1):11-30
pubmed: 23335087
Cancer. 2020 Jan 1;126(1):46-57
pubmed: 31553489
Hinyokika Kiyo. 2004 Jan;50(1):57-9
pubmed: 15032019
Cancer. 2020 Jan 1;126(1):17-18
pubmed: 31553480
Biomed Res Int. 2017;2017:1438027
pubmed: 28265568
Nat Rev Urol. 2014 Jun;11(6):317-23
pubmed: 24818853
J Urol. 1987 May;137(5):888-90
pubmed: 3573183